Conference Information

Welcome Message

Dear esteemed visitors and Participants,

Good Day!

On behalf of our committee on the organisation's Neurology 2023 forum, with great privilege we’re announcing the "6th Edition of the International Conference on Neurology and Therapeutics," which is scheduled for a fantastic three-day event from October 12–14, 2023, with its high quality and exceptional value for students, scholars, and industry researchers as a collaborative meeting in the splendid city of Paris, France.

The Neurology 2023 Forum intends on bringing together renowned academic scientists, researchers, and research scholars to interact and share their experiences and research findings on all aspects of general neurology under the theme of "Pedagogic New Vistas Towards the Future Advancement of Neurology and Therapeutics"

With the Neurology 2023 Conference's premier global gathering platform, we welcome all experts from different parts of the world for optimistic networking and collaboration, updating our knowledge base and providing a great forum for exploring neurology and therapeutics.

The Gathering consists of different neurological interactive sessions that are totally meant for immensely praised academic activities, and it is widely considered as one of the field's most prominent events. The objective of the sixth Neurology Consortium is to enhance the interdisciplinary approach for current neuroscience studies, innovation, and creation.

We eventually look forward to presenting you with a rewarding experience at Neurology 2023, which will be held on October 12-14, 2023 in Paris, France.

Best Regards,
Organizing & Programming Committee
Neurology 2023

About Conference

The Neurology 2023 conferences are a significant meeting place for academic researchers and business executives. "It incorporates a diversity of lectures, intriguing breakout sessions, hands-on product demonstrations, and incredible networking opportunities".

Some of the world's most sought-after keynote speakers, professionals, brand ambassadors, and industry leaders have been asked to share their views and ideas with our conference attendees.

Reason to attend the Neurology conference in France:

As Neurology research in France has advanced significantly in recent years, with a focus on improving the diagnosis, treatment, and management of neurological disorders, such as advanced imaging techniques and several studies in stem cell treatments of neurological disorders, neurology research in France has advanced significantly in recent years, with a focus on developing innovative techniques and therapies for the diagnosis and treatment of neurological disorders, such as advanced imaging techniques and several studies in stem cell treatments of neurological disorders.

The Neurology market in France is predicted to develop as the population ages and neurological illnesses become more prevalent. According to Grand View Research, the worldwide neurology market will develop at a CAGR of 6.3% from 2020 to 2027, with France likely to be a prominent participant in the European industry.

Potential Audience at Neurology 2023 Forum:

Neurologists
Neurosurgeons
Neuroscientists
Neurology Nurses
Neuropsychologists
Neurology Students
Neurology Residents
Biomedical Engineers
Neurology Researchers
Neuroimaging Specialists
Pharmaceutical Industry Representatives
Medical Device Industry Representatives

Call For Grants:

The Neurology 2023 Conference welcomes all experts in neurology to contribute their research abstracts, papers, and e-posters to the conference and to help shape the event with their contributions. The organizers are seeking high-quality research contributions in all areas of general neurology, including conceptual, constructive, empirical, experimental, or theoretical work. The conference welcomes Abstracts, Posters, and e-posters that address the conference's themes and topics and include figures, tables, and references to novel research materials.

All acceptance abstract will be published in a high-indexing international journal.
Exposure to new ideas in Neurology
Networking sessions

Benefits for Exhibits & Sponsorship at Neurology 2023 Forum:

Exposure to a targeted and engaged audience of professionals in your field
Opportunity to showcase your products, services, and expertise to a global audience
Networking opportunities with fellow exhibitors, sponsors, and conference attendees
Brand exposure through signage, marketing materials, and conference collateral
Access to exclusive conference sessions and events

Comprehensive, Exhibiting and Sponsoring at a Global Gathering on Neurology 2023 conference can be an effective way to establish your brand, generate new leads, and develop valuable business relationships within your industry.

Market Analysis

Neurology Market Analysis:

In 2022, the worldwide Neurology market was worth USD 5,235.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2023 to 2038. This is largely attributed to increasing neurological diseases, such as dementia, stroke, and peripheral neuropathy, plus growing R&D investments in neurological research.

Sponsors and investors are becoming more interested in supporting neurological clinical research due to the significant burden of neurological illnesses worldwide. Neurological trials have received substantial funding throughout the years. For instance, in March 2022, the NIH awarded USD 16.0 million to a group of scientists from Brown University, New York University, and the University of Rochester to assist their work on Alzheimer's disease. Future sector market growth is anticipated to be supported by such activities.

Neurology Devices Market Analysis:

All across the planning horizon, it is anticipated that the market for neurology devices will grow at a CAGR of roughly 8.41%. (2022–2028).

The COVID-19 pandemic had a tremendous influence on the world's healthcare systems, with serious repercussions for those who were infected as well as for others. As a result, treatment and surgical treatments had to be postponed in order to manage and conserve resources. The World Health Organization, for instance, revealed in June 2020 the findings of a survey it had conducted in 155 countries over the course of three weeks in May 2020, which revealed that the services for the prevention and treatment of numerous chronic diseases, including numerous neurodegenerative disorders like Parkinson's, Alzheimer's, and dementia, had been severely disrupted. Considering people who have long-term illnesses are more likely to suffer from severe COVID-19-related sickness and pass away, this has grown to be a major worry. In addition, 53% of the nations experienced total or partial service interruptions. The patients' lives have been harmed by this disturbance in the treatment of various neurological diseases. Also, the pandemic may negatively affect new product releases, which are thought to be the main driver of the market's expansion. For instance, Biogen put off submitting Alzheimer's and dementia medications to the Food and Drug Administration (FDA) in April 2020, citing the difficulty of data processing and the effect COVID-19 had on its R&D resources. With the restoration of services, the need for neurology equipment and treatments for numerous neurological disorders is expected to grow, which will have an impact on marketplace growth.

Applications Insights:

Besides a market share of over 34% in 2020, the Alzheimer's disease application sector is anticipated to maintain its dominance throughout the next years. The high prevalence of the illness and the accessibility of clinically useful goods, such as imaging biomarkers and amyloid PET tracers for diagnosis, are credited with this increase. The government and non-profit organizations are also offering a wealth of research possibilities that might stimulate industry expansion. The Michael J. Fox Foundation for Parkinson's Research (MJFF), Alzheimer's Research U.K., and the Weston Brain Institute joined forces to form the Biomarkers Across Neurodegenerative Disorders (BAND) initiative, which offers financing for biomarker research. Over the projected period, the Parkinson's disease application category is anticipated to expand at a CAGR of 13.2% due to the rising illness prevalence and rising number of clinical trials for the disease's treatments throughout the projection period. Almost 930,000 Americans had Parkinson's disease as of 2020, according to the Parkinson's Foundation, which estimates that 60,000 Americans are diagnosed with the condition year.

Regional Insights:

Towards a 47.0% revenue share in 2022, North America dominated the market for neurology clinical trials. The market for neurology clinical trials in the area is being driven by the increased frequency of neurological illnesses and the existence of several companies in clinical trials. Dementia will grow increasingly prevalent as the population ages and overall life expectancy rises; by 2030, it is predicted that 8.4 million Americans aged 65 and older will have Alzheimer's disease or another form of dementia. The largest CAGR of 5.9% is anticipated for Asia Pacific throughout the projection period. Due to the fact that many developed countries are investing in the Asia Pacific area, this market is expanding at the quickest rate. Compared to North America and Europe, clinical trial enrollment is rising in Asia. The vast patient pool and affordable trial expenses are to blame for this. Also, novel neurological therapies are being actively developed in the area.

Market Value of Neurological research:

The US comprises 74% of the $34.5 billion worldwide market for neurology, followed by Europe (64%), Japan (8.3%), and the UAE (7.8%).

The market value of neurological research is difficult to quantify as it encompasses a broad range of areas such as neurodegenerative diseases, brain injury, neuroimaging, neuropsychiatry, and more. However, it is safe to say that the market value of neurological research is significant and growing rapidly.

According to a report by Grand View Research, the global neurological disorder drugs market size was valued at USD 140.7 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. This growth is driven by the increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy, among others.

In addition to drug development, the market value of neurological research extends to neuroimaging technologies, neurostimulation devices, and personalized medicine approaches. The global market for neurostimulation devices, for example, was valued at USD 4.15 billion in 2020 and is expected to reach USD 9.05 billion by 2028, growing at a CAGR of 10.2% from 2021 to 2028.

Funding Agencies for Neurology Research:

National Institute of Neurological Disorders and Stroke (NINDS)
Brain Research through Advancing Innovative Neurotechnologies (BRAIN)
Michael J. Fox Foundation for Parkinson's Research
Alzheimer's Association
National Multiple Sclerosis Society
The Epilepsy Foundation

NINDS Funding Strategy- FY 2023:

The NINDS Funding for FY 2023 includes a $239.5 million increase in the Research Project Grants portfolio, which includes SBIR and STTR grants. As compared to the FY 2022 CR level, competing RPGs are predicted to raise their awards by 193.

Sessions & Tracks

Session: Neurology and Neuroscience

Name: 6th International Conference on Neurology and Therapeutics
Start: 2023-10-12
End: 2023-10-14
Location: France

Clinical trials and clinical research are both carried out by neurologists who specialize in the diagnosis and treatment of neurological illnesses. While neurology is a non-surgical specialty, neurosurgery involves the surgical specialty. In order to develop new therapeutic medicines to treat and cure the sickness, numerous scientific and clinical studies are being conducted on neurological illnesses. Epilepsy, Alzheimer's, stroke, and other illnesses are among the 600 recognized disorders.

Neurodegenerative disorders
Cerebrovascular diseases
Peripheral nervous system
General neurology
Behavioral neurology

Session: Neurosurgery and Spine

The top concerns of a neurosurgeon are diagnosis and therapy. After surgery, the patient transitions to rehabilitation treatment, typically in a different hospital, and is no longer directly under the neurosurgeon's care. Neurosurgeons frequently practice in hospitals, and when the patient is released, they may have little more interaction with them. To legally practice neurospinal surgery, a person must confront different criteria in each country, and there are several ways that person must be educated.

General/Trauma Spine Neurosurgery
Scoliosis
Vascular neurosurgery
Stereotactic neurosurgery/ functional neurosurgery

Session: Neurological Disorders and Stroke

The progressive loss of neurons' structure and function is the main cause of neurological diseases. Neurons may also perish as a result of it. medicine Diseases like Parkinson's, ALS, Huntington's, etc. may be brought on by disorders. Many analyses are being conducted, yet some illnesses cannot be cured. It causes the death or degeneration of nerve cells. Several treatment choices as well as psychological traits and behaviors are brought on by this decline.

Muscular Dystrophy
Transient Ischemic Attack
Cerebral Aneurysm
Pain management
Peripheral Neuropathy

Session: Pediatric Neurology and Epilepsy

Pediatric neurology, often known as child neurology, deals with children's CNS, PNS, brains, and spinal cord disorders. This section of neurology is concerned with the aforementioned problems in newborns and adolescents. Epilepsy brought on by aberrant brain activity are known as epilepsy. Every brain-coordinated process can be impacted by seizures. Epilepsy affects over 50 million individuals worldwide, making it one of the most prevalent neurological conditions worldwide.

Sleep disorders
Cerebral palsy
Neonatal neurology
Generalized seizures
Tonic-clonic seizures

Session: CNS Injury, Repair and Inhibition, Excitation

Stroke, traumatic brain injury, and spinal cord injuries are all examples of acute central nervous system (CNS) injuries. For individuals with stroke or traumatic brain damage, early brain injury is a major factor in disability and mortality. Regrowth or repair of neural tissues, cells, or cell products are referred to. These methods might include the development of brand-new synapses, glia, axons, or myelin. The functional processes involved in neurodegeneration are different between the peripheral nervous system (PNS) and the central nervous system (CNS), notably in the scope and rate of repair. A damaged axon will experience Wallerian degeneration, which will result in the distal portion losing its myelin sheath. the propagation of electrical activity in a neuron or muscle cell in response to an external stimulus of an action.

Focal Injury
Diffuse Injury
Cranial nerves
Difference from the peripheral nervous system

Session: Psychiatry and Psychology

The specialty of medicine and science known as neuropsychiatry deals with mental illnesses connected to the neurological system. The combined study of neurology and psychiatry is known as neuropsychiatry. In light of changing demographics and the increased frequency of these problems in children and adolescents, psychiatric and neurological disorders are becoming more common in society. Neuropsychiatric diseases are the major cause of impaired quality of life and diminished capacity to perform. In Europe, neuropsychiatric disorders account for more than 42% of years with a disability.

Psychiatric genetics
Mental well-being and mental illness
Psychoanalytic Theories & Evolutionary Psychology

Session: Neuroscience Nurse

The Neuroscience Nurse has a very difficult job since her field of study deals with people and the spread of neurological diseases and problems across the lifetime in all types of healthcare facilities. The goal of neurology events is to identify nursing chances that can have the greatest impact on people's capacity to avoid and treat severe neurological illnesses. Numerous neuro conferences subspecialties fall under this field of practice, including (but not limited to) geriatric nursing, neurosurgery, neurotrauma, neuroscience critical care, long-term neurological disorders like Parkinson's disease and epilepsy, as well as life-limiting neurological disorders like motor neuron disorder and Huntington's disease.

Advance Practice Nursing
Nursing Physicians
Movement Disorders carers
Neuroscience Intensive Care Unit

Session: Neuropharmacology and Neurochemistry

Behavioral Neuropharmacology is the study of how drugs impact human behavior (neuropsychopharmacology), including the study of how drug dependency and addiction affect the human brain. Molecular neuropharmacology is the study of neurons and their neurochemical interactions with the overarching objective of finding medications that improve neurological function.

Neurochemistry is the study of neurotransmitters, chemicals, and other compounds, such as neuropeptides and psychopharmaceuticals, that affect and govern the CNS. This discipline investigates the effects of neurochemicals and their functions in neurons and neural networks.

Neurochemical Interactions
Neurotransmitters
Current research in Neuropharmacology
Study of drugs for Neurological Disorders

Session : Brain Pathology and Neuro-oncology

Any ailment, disease, or pathological condition affecting the brain (e.g., tumor, stroke, traumatic injury). Pathology is the study of the causes and consequences of illness or damage. Pathology emphasizes illness components such as the source, techniques of growth (pathogenesis), structural changes in cells (morphologic changes), and the outcome of modifications (clinical manifestations).

Metastatic tumors
Treatment and advancement in neuropathology
Neuropathology approaches
Functional Neuroanatomy

Session: Cognitive science

Cognitive scientists study how attention works and how it affects perception, memory, and decision-making. Attentional processes help individuals focus on important information and filter out irrelevant information. Memory is a key area of study within cognitive science. Researchers investigate how information is stored in the brain, how memories are retrieved, and how we forget information. Memory is essential to many cognitive processes, including learning, problem-solving, and decision-making.

Cognitive Neuroscience
Computational Models
Cognitive Aging
Consciousness and Metacognition

Session: Alzheimers and Parkinsons Diseases

Alzheimer's disease is the leading cause of dementia, accounting for 60-80% of all cases. It often develops slowly over time, with symptoms growing progressively severe as time passes.

Parkinson's disease affects about 1% of people over the age of 60. Parkinson's disease can induce non-motor symptoms such as sadness, anxiety, and sleep difficulties in addition to motor symptoms such as tremors and stiffness. The illness is caused by the loss of dopamine-producing cells in the substantia nigra, a part of the brain.

Neurobiology- neurotransmitters in motor control
Neuroprotection and Neurorestoration
Biomarkers and Early Detection
Sleep and Circadian Rhythms
Deep Brain Stimulation (DBS)

Session: Neurorobotics

The biological brain of the robot is built up of cultivated neurons that are put on a multi electrode array (MEA). The MEA is a dish with around 60 electrodes that detect electrical impulses produced by cells. This is then utilised to control the robot's mobility. Deep learning and neural networks are artificial intelligence approaches that mimic the structure and function of the brain. In neurorobotics, these approaches have been utilised to create intelligent robotic systems that can learn from experience and adapt to new conditions.

Neural Control and Learning
Sensory Processing and Perception
Brain-Computer Interfaces and Neurofeedback
Robotics and Automation
Neuromorphic Engineering

Session: Molecular Genetics and Neurobiology

Molecular genetics and neurobiology study how genes and chemicals affect brain development and contribute to the emergence of neurological illnesses. This discipline integrates methodologies from genetics, molecular biology, biochemistry, and neuroscience to study the molecular and cellular mechanisms that underpin nervous system development and function. Researchers in this field explore the genetic and molecular foundation of brain development, function, and illness using techniques such as gene editing, genome-wide association analyses, and molecular imaging.

Neurogenetics
Gene Expression and Regulation
Neural Circuits and Behavior
Neural Development and Plasticity

Session: Neuroimaging , Neural Engineering & Radiology

Neuroimaging is distinct from neuroradiology, a medical speciality that employs brain imaging in a clinical environment. Radiologists, who are medical practitioners, practise neuroradiology. The primary goal of neuroradiology is to detect brain abnormalities such as vascular disease, strokes, tumours, and inflammatory illness. Neuroradiology, unlike neuroimaging, is qualitative (based on subjective perceptions and substantial clinical training) but occasionally employs basic quantitative tools. Neuroimaging is divided into two categories: Structural imaging is used to measure brain structure using methods such as voxel-based morphometrics. Functional imaging is used to examine brain function, and it frequently employs fMRI as well as other methods such as PET and MEG.

Functional Neuroimaging
Imaging Genetics and Genomics
Radiomics and Radiogenomics
Neuroimaging and Neurodevelopmental Disorders

Session: Ophthalmology and Visual Neuroscience

Ophthalmology is a surgical and medical specialty concerned with the diagnosis and treatment of eye problems. Strabismus/pediatric ophthalmology, glaucoma, neuro-ophthalmology, retina/uveitis, anterior segment/cornea, oculoplastic/orbit, and ocular oncology are all subspecialties within this intriguing surgical field. The primary objective of visual neuroscience is to understand how brain activity results in visual perception and vision-dependent behavior.

Retina and Macular Diseases

Glaucoma and Optic Neuropathies

Corneal and External Diseases

Visual Perception and Cognition

Session: Neuroinfections and Neuroimmunology

The contemporary debate on neuroimmunology is gaining attention for the precise reason. The brain and the immune system are inextricably linked. A greater knowledge of the interplay between these two systems through neuroimmunology demonstrates the explicit study of medicine's future. Neuroimmunology and neuroinflammation are linked to the genesis of autism, multiple sclerosis, Alzheimer's and AIDS-related dementia, and other neuro-related disorders. Because of insufficient laboratory and surgical procedures, neuroinfectious disorders are difficult to detect. Despite the fact that antimicrobials have a limited function in treating Brain infections, researchers are looking for remedies. Immune system dysregulation and immunological bonding will lead to significant consequences of auto-immune neural diseases. Neuroimmunology research tends to produce novel therapies with unequivocal outcomes for nerve and neurologic disorders.

Pathogenesis of Neuroinfections
Autoimmune Neurological Diseases
Immune-Mediated Neurological Disorders
Immunotherapy for Neurological Diseases

Session: Neurorehabilitation & Neuroplasticity

The Rehabilitation process shows how a neurulation recovers from their current status to lead a normal life. It also specifies the techniques utilized in the rehabilitation process, such as virtual reality simulations for locomotor interface for Parkinson's disease patients. Structural robotics help spine-injured people recover faster, whereas speech therapy and physiotherapy are the most common types of rehabilitation.

Neuroplasticity, also known as brain plasticity and neural plasticity, refers to advances in neuronal networks and synapses caused by differences in behaviour, environment, neurological processes, thinking, and emotions, as well as changes caused by physical changes.

Mechanisms of Neuroplasticity
Rehabilitation Technology and Assistive Devices
Neuroplasticity and Pain

Session: Clinical Trials & Ethical Challenges in Neurology

Neuro scientists are rapidly expanding their preclinical and clinical investigations. Drug development and delivery in neurology are challenging, as they can lead to lethal consequences. Clinical trials organisations thoroughly evaluate adverse responses to CNS drugs to ensure that all trial stages are met.

Therapeutic Advances in Neurology
Ethics of Clinical Research in Neurology
Clinical Trials and Stroke
Clinical Trials and Epilepsy

Past conference Report

The 5th International Conference on Neurology and Therapeutics was successfully held on July 7-8, 2021 in Paris, France, with the theme "Comprehensive Perspectives on Future Neurology and Therapeutics". The conference was hosted by his Pulsus and brought together more than 50+ of his attendees, including researchers, clinicians, neurologists and other medical professionals from around the world.

The conference provided attendees with an excellent platform for discussing the latest research and developments in the fields of neurology and therapeutics. The conference featured a series of keynotes, plenary sessions and poster presentations covering a wide range of topics related to neurology and therapeutics. During his two days at the conference, there were several sessions on various topics related to neurology and therapy, including neurodegenerative diseases, neuroimaging techniques, neuropharmacology, and neurorehabilitation. The session was very informative and provided valuable insight into the latest research in this area.

In addition to keynotes and plenary sessions, the conference also provided opportunities for researchers to present their latest research findings in oral and poster presentations. This provided a great opportunity for participants to network and exchange ideas with other experts in the field. One of the highlights of the conference was a panel discussion on the topic "The Future of Neurology and Therapeutics". The panel was led by Dr. Mark Hallett, chaired by Dr. Joanna Wardlow, Dr. Michael Brainin and Dr. Jean-Marc Orgozo. Panel discussions focused on the latest developments in neurology and therapeutics, including challenges in developing effective treatments for neurological disorders.

Overall, the 5th International Conference on Neurology and Therapeutics was a great success, providing attendees with an excellent platform to exchange ideas, share knowledge and learn about the latest advances in the field. bottom. This conference has helped foster collaborations and partnerships that will undoubtedly lead to new breakthroughs and developments in the fields of neurology and therapeutics.